UB McNair Graduate School Visit
Thursday July 15, 2010 -- 8:30 am - 12:30 pm
Buses depart from the Conference Center at 7:30 am
The University at Buffalo Graduate School Visit provides an excellent opportunity for students to learn about the UB Graduate School Experience. You will be able to visit UB’s campus and network with faculty from your graduate school area of interest.
The 2010 Graduate School Visit includes:
-
Transportation from the Conference site to the University at Buffalo!
-
Continental breakfast
-
Presentation by UB faculty
-
Departmental visits & meetings with program faculty that interest you!
-
Boxed lunch
-
Frequently Asked Questions about the event
-
Learn more about the graduate programs at UB
Opening Speaker: Dr. Margarita Dubocovich, Professor and Chair
Pharmacology & Toxicology, University at Buffalo
Margarita L. Dubocovich, PhD became the first female Chair of the Department of Pharmacology and Toxicology in the School of Medicine and Biomedical Science at the University at Buffalo on November 1, 2008. She was previously Professor in the Department of Molecular Pharmacology and Biological Chemistry and the Department of Psychiatry and Behavioral Science at Northwestern University Feinberg School of Medicine in Chicago, Illinois. Dr. Dubocovich received her PhD in Pharmacology at Buenos Aires University in Argentina. She was a research fellow of the National Research Council of Argentina. She worked in the pharmaceutical industry in the UK and France, acquiring experience in the discovery and development of new therapeutic agents for the treatment of psychiatric disorders.
Dr. Dubocovich is known internationally for her work on melatonin receptors, which has provided the tools and guidance for the discovery of melatonin receptor ligands and the development of analogues with therapeutic potential for the treatment of sleep and circadian disorders, depression, and cancer. Dr. Dubocovich’s work on topics related to the role of melatonin receptor activation on the modulation of signaling, circadian rhythms and of light-induced melatonin suppression as a new risk factor for human breast cancer has been published in numerous peer-reviewed scientific journals. Dr. Dubocovich’s research has been consistently funded by the National Institute of Health (NIH). She currently holds research grants from the National Institute of Mental Health (NIMH), the National Institute of Drug Abuse (NIDA) and the National Institute of Neurological Disorders and Stroke (NINDS). She holds several patents related to novel melatonin agonists and antagonists.
Dr. Dubocovich has taught medical and graduate students, mentors students, post-docs, and faculty, and has participated in training undergraduate students to pursue careers in pharmacology. She has received funding to support these activities from American Society for Pharmacology and Experimental Therapeutics (ASPET) through the Summer Undergraduate Research Fellowship (SURF) Institutional award and also the Federation of American Societies on Experimental Biology (FASEB) MARC Program. She is the Director of The CLIMB (Collaborative Learning and Integrated Mentoring in the Biosciences) Program at UB that she established at UB in 2009, having founded The CLIMB Program at Northwestern in 2007. The Program mentors and promotes the scientific careers of undergraduate, graduate, and postdoctoral fellows to become leaders in the biomedical sciences.
Dr. Dubocovich is a member of several professional societies, including the Society for Neuroscience, the British Pharmacological Society, ASPET, and the American College of Neuropsychopharmacology. She served as Chair of the Committee on Diversity and Secretary-Treasurer of the Neuropharmacology Division of ASPET. Dr. Dubocovich chairs the IUPHAR Subcommittee on Melatonin Receptor Nomenclature and Classification, where she was the driving force behind the establishment of the current melatonin receptor nomenclature and classification. She is Associate Editor of the Journal of Pineal Research.
Last Modified: 06/11/10
